$165 Million is the total value of SV Health Investors, LLC's 10 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MSON | MISONIX, INC. | $31,562,000 | -7.4% | 1,695,969 | 0.0% | 19.12% | -20.2% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $30,625,000 | +53.5% | 1,719,576 | 0.0% | 18.55% | +32.4% | |
| AVRO | AVROBIO INC | $28,528,000 | +42.6% | 1,417,204 | 0.0% | 17.28% | +22.9% | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS INC | $28,005,000 | +52.2% | 449,951 | -17.0% | 16.96% | +31.2% |
| STRO | SUTRO BIOPHARMA INC | $20,070,000 | +21.0% | 1,824,542 | 0.0% | 12.16% | +4.4% | |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $18,061,000 | -17.2% | 1,915,274 | 0.0% | 10.94% | -28.6% | |
| XFOR | X4 PHARMACEUTICALS INC | $3,333,000 | -15.8% | 311,490 | 0.0% | 2.02% | -27.3% | |
| OCUL | OCULAR THERAPEUTIX INC | $2,482,000 | +29.9% | 628,236 | 0.0% | 1.50% | +12.0% | |
| CATABASIS PHARMACEUTICALS IN | $1,689,000 | +9.5% | 285,765 | 0.0% | 1.02% | -5.6% | ||
| TRXC | Sell | TRANSENTERIX INC | $750,000 | -81.8% | 510,142 | -92.3% | 0.45% | -84.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- SVLSF VI, LLC #1
- SV Life Sciences Fund VI (GP), L.P. #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSENTERIX, INC. | 27 | Q4 2020 | 24.0% |
| OCULAR THERAPEUTIX, INC. | 24 | Q2 2020 | 35.9% |
| KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 31.0% |
| DECIPHERA PHARMACEUTICALS INC | 17 | Q3 2021 | 31.0% |
| CATABASIS PHARMACEUTICALS, INC. | 15 | Q4 2018 | 18.2% |
| X4 PHARMACEUTICALS INC | 15 | Q3 2022 | 3.2% |
| BICYCLE THERAPEUTICS PLC | 14 | Q3 2022 | 65.4% |
| SUTRO BIOPHARMA INC | 14 | Q4 2021 | 19.1% |
| ENTELLUS MED INC | 12 | Q4 2017 | 64.4% |
| AVROBIO INC | 12 | Q1 2021 | 41.6% |
View SV Health Investors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
View SV Health Investors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.